Elizabetta A Renzoni
25PUBLICATIONS
83CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (25)
Sort by Publication Date:
|Dec 24, 2025
Survival in patients with pulmonary hypertension associated with fibrotic interstitial lung disease (ILD) is independent of ILD subtype.Ifan Jenkin, Konstantinos Dimopoulos, Steven D Nathan
|Mar 12, 2025
Objective Effects and Patient Preferences for Ambulatory Oxygen in Fibrotic Interstitial Lung Disease With Isolated Exertional Hypoxaemia: A Placebo-Controlled 6-Minute Walk Test Study.Giuseppina Ciarleglio, Paolo Cameli, David Bennett
|Jan 03, 2025
Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis.Nina R Goldman, Svetlana I Nihtyanova, Claire F Beesley
|Oct 02, 2023
Serum C-reactive protein is associated with earlier mortality across different interstitial lung diseases.Carmel J W Stock, William G Bray, Vasilis Kouranos
|Dec 26, 2022
MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis.Joanne J van der Vis, Antje Prasse, Elisabetta A Renzoni
|Sep 29, 2022
Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study.Timothy J W Dawes, Colm McCabe, Konstantinos Dimopoulos
Pageof 5
Frequent Collaborators
7 joint publications
Athol U Wells
5 joint publications
Carmel J W Stock
4 joint publications
Raphael Borie
4 joint publications
Felix Chua
3 joint publications
Peter M George
3 joint publications
Toby M Maher
2 joint publications
Joseph Jacob
2 joint publications
Francesco Bonella
2 joint publications
Christopher J Ryerson
2 joint publications
David J Lederer
